ITMI20000312A0
(en )
2000-02-22
FORMULATIONS CONTAINING AN ANTICHOLINERGIC DRUG FOR THE TREATMENT OF CHRONIC OBSTRUCTIVE LUNG DISEASE
IL196301A0
(en )
2009-09-22
Medicament for the treatment of hapatitis c
IL150742A0
(en )
2003-02-12
Pyridopyrimidinone derivatives for the treatment of neurodegenerative disease
IL160884A0
(en )
2004-08-31
Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
IL159344A0
(en )
2004-06-01
Quinuclidines-substituted-multicyclic-heteroaryls for the treatment of disease
AU9287401A
(en )
2002-04-08
Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
HUP0303952A3
(en )
2012-09-28
Remedies for infant chronic arthritis-relating diseases
AU2001276860A1
(en )
2002-01-30
Medicaments for chemotherapeutic treatment of disease
AU2002312897A1
(en )
2002-11-25
Drugs for the treatment of the alzheimer disease
HRP20020893A2
(en )
2004-02-29
Formulations containing a glucocorticoid drug for the treatment of bronchopulmonary diseases
IL153831A
(en )
2013-03-24
Pharmaceutical composition for therapy of neurodegenerative disease of the brain
FI20000780L
(en )
2001-10-04
Oral dosage form for controlled release of the drug
GB0004531D0
(en )
2000-04-19
The treatment of respiratory diseases
PL356605A1
(en )
2004-06-28
Drug combination for the treatment of depression and related disorders comprising mirtazapine and gepirone
HUP0102159A3
(en )
2004-01-28
Pharmaceutical composition for the treatment of rumen acidosis
HU0102388D0
(en )
2001-08-28
Diazepinoindoles for the treatment of chronic obstructive pulmonary disease
HUP0204391A3
(en )
2005-03-29
The use of mirtazapine for the preparation of pharmaceutical composition suitable for the treatment of sleep disorders
IL155237A0
(en )
2003-11-23
Combination therapy for the treatment of estrogen-sensitive disease
AU2562501A
(en )
2002-05-15
Use of melagatran for manufacture of a medicament for the treatment of ischemic disorders
AU4335901A
(en )
2001-09-12
Novel therapeutic treatment of chronic obstructive pulmonary disease
EP1448203A4
(en )
2010-05-26
Pharmaceutical formulations comprising substituted xanthine compounds
SI1257254T1
(en )
2006-02-28
Formulations containing an anticholinergic drug for the treatment of chronic obstructive pulmonary disease
IL151188A0
(en )
2003-04-10
Medicament for viral diseases
AU2002351798A1
(en )
2003-05-12
Methods and dosage forms for improving the bioavailability of therapeutic agents
AU2002348105A1
(en )
2003-05-12
Oral dosage forms for improving the bioavailability of therapeutic agents